# A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia

Study · id `cardio:ct-nct05820035` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05820035](<https://clinicaltrials.gov/study/NCT05820035>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05820035

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 164 participants.

## Technical summary

Registry record NCT05820035. Allocation not applicable; no masking; primary purpose treatment. Start 2023-03-09 (actual); primary completion 2024-02-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 164 participants (enrolled count; ClinicalTrials.gov record NCT05820035, source copy `cardio:ctgov-nct05820035-2025-05-28`, retrieved 2026-10-26)
- Started: 2023-03-09 (actual) (ClinicalTrials.gov record NCT05820035, source copy `cardio:ctgov-nct05820035-2025-05-28`, retrieved 2026-10-26)
- Primary completion: 2024-02-23 (actual) (ClinicalTrials.gov record NCT05820035, source copy `cardio:ctgov-nct05820035-2025-05-28`, retrieved 2026-10-26)
- Completion: 2024-12-09 (actual) (ClinicalTrials.gov record NCT05820035, source copy `cardio:ctgov-nct05820035-2025-05-28`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05820035, source copy `cardio:ctgov-nct05820035-2025-05-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05820035-2025-05-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia
- Acronym: PSVT
- Condition: Paroxysmal Supraventricular Tachycardia
- Condition: Atrioventricular Nodal Reentrant Tachycardia
- Condition: Atrioventricular Reciprocating Tachycardia
- Intervention (Device): Pulsed Field Ablation Device and CF-Sensing Pulsed Field Ablation Catheter
- Lead sponsor: Shanghai MicroPort EP MedTech Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Shanghai MicroPort EP MedTech Co., Ltd. (`cardio:org-shanghai-microport-ep-medtech-co-ltd`)

## Provenance

Content hash: 54fb4843b6c43eacae1d0bc039a3e484b969c39d4193b66b7ba50efa37ea337c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
